Heron Therapeutics
HRTX
HRTX
100 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.64% less ownership
Funds ownership: 134.39% → 133.75% (-0.64%)
19% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $1.68M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
100
Holding in Top 10
4
Calls
$1.36M
Puts
$1.68M
Top Buyers
| 1 | +$39.8M | |
| 2 | +$36.9M | |
| 3 | +$34.6M | |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
+$33M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.4M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$6.37M | |
| 3 | -$5.32M | |
| 4 |
Millennium Management
New York
|
-$3.37M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.95M |